Closed Suction Drainage After Revision Hip Arthroplasty
Primary Purpose
Hip Osteoarthritis, Bleeding
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Drainage
No-drainage
Sponsored by
About this trial
This is an interventional treatment trial for Hip Osteoarthritis focused on measuring Hip, Revision, Arthroplasty, Drainage
Eligibility Criteria
Inclusion Criteria:
- aseptic loosening,
- head or insert damage,
- girdlestone hip
Exclusion Criteria:
- septic loosening,
- primary or secondary coagulopathy,
- renal or hepatic failure,
- thromboembolism in past history
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Drainage group
No-drainage group
Arm Description
Patients with drainage after hip revision arthroplasty
Patients without drainage after hip revision arthroplasty
Outcomes
Primary Outcome Measures
Hematoma size
Level of fluid at endoprosthesis neck in ultrasonography
Hemoglobin level
Hemoglobin level after surgery on 1st and 3rd day after surgery
Blood loss
Assessing blood loss with use of Gross formula
Reinfection
Number of patients with infection after surgery performed in the study
Secondary Outcome Measures
Soft tissue hematoma
Note hematoma formation in soft tissue after surgery (ultrasonography)
C-reactive protein level
Level of C-reactive protein after surgery
Blood transfusion
Number of patients who need blood transfusion after surgery
Visual Analog Scale
Level of pain after surgery, 1- no pain; 10- "the worst pain you ever had"
Harris Hip Score
Clinical outcome after surgery, 0-100 points; 100 points the best score
Full Information
NCT ID
NCT04486040
First Posted
July 22, 2020
Last Updated
August 2, 2021
Sponsor
Prof A Gruca Teaching Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04486040
Brief Title
Closed Suction Drainage After Revision Hip Arthroplasty
Official Title
Closed Suction Drainage After Revision Hip Arthroplasty - Prospective Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
March 14, 2016 (Actual)
Primary Completion Date
March 13, 2018 (Actual)
Study Completion Date
March 13, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Prof A Gruca Teaching Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective, randomized trial. 40 patients who underwent revision hip arthroplasty, divided in to two groups with or without drainage. All patients was assessed with ultrasonography on 3rd day after surgery. Bleeding, need for blood transfusion and laboratory test was analyzed after surgery. Patients was assessed with Harris Hips Score and Visual Analog Scale after surgery.
Detailed Description
Inclusion criteria: aseptic loosening, head or insert damage, girdlestone hip. Exclusion criteria: septic loosening, primary or secondary coagulopathy, renal or hepatic failure, thromboembolism in past history. At the end of operation information of drainage was get out from the envelope. On 3rd day all patient get ultrasonography with level of fluid in the joint and hematoma in soft tissue measurement. We analyzed hemoglobin, C-reactive protein, erythrocyte sedimentation rate on 1st and 3rd day after surgery. Visual analog scale was taken on 3rd day after surgery and Harris Hip Score 6 weeks after.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Osteoarthritis, Bleeding
Keywords
Hip, Revision, Arthroplasty, Drainage
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
38 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Drainage group
Arm Type
Active Comparator
Arm Description
Patients with drainage after hip revision arthroplasty
Arm Title
No-drainage group
Arm Type
Active Comparator
Arm Description
Patients without drainage after hip revision arthroplasty
Intervention Type
Procedure
Intervention Name(s)
Drainage
Intervention Description
Use of the suction drainage after hip revision arthroplasty
Intervention Type
Procedure
Intervention Name(s)
No-drainage
Intervention Description
Patients without drainage after surgery
Primary Outcome Measure Information:
Title
Hematoma size
Description
Level of fluid at endoprosthesis neck in ultrasonography
Time Frame
3 days after surgery
Title
Hemoglobin level
Description
Hemoglobin level after surgery on 1st and 3rd day after surgery
Time Frame
3 days after surgery
Title
Blood loss
Description
Assessing blood loss with use of Gross formula
Time Frame
1 day after surgery
Title
Reinfection
Description
Number of patients with infection after surgery performed in the study
Time Frame
2 years after surgery
Secondary Outcome Measure Information:
Title
Soft tissue hematoma
Description
Note hematoma formation in soft tissue after surgery (ultrasonography)
Time Frame
3 days after surgery
Title
C-reactive protein level
Description
Level of C-reactive protein after surgery
Time Frame
3 days after surgery
Title
Blood transfusion
Description
Number of patients who need blood transfusion after surgery
Time Frame
5-14 days after surgery
Title
Visual Analog Scale
Description
Level of pain after surgery, 1- no pain; 10- "the worst pain you ever had"
Time Frame
3 days after surgery
Title
Harris Hip Score
Description
Clinical outcome after surgery, 0-100 points; 100 points the best score
Time Frame
6 weeks after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
aseptic loosening,
head or insert damage,
girdlestone hip
Exclusion Criteria:
septic loosening,
primary or secondary coagulopathy,
renal or hepatic failure,
thromboembolism in past history
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pawel Bartosz
Organizational Affiliation
Gruca Teaching Hospital, Centre of Postgraduate Medical Education in Otwock
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Closed Suction Drainage After Revision Hip Arthroplasty
We'll reach out to this number within 24 hrs